Detalhe da pesquisa
1.
Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection.
Anaerobe
; 48: 1-6, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28645479
2.
An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series.
Pharmacotherapy
; 34(9): 901-9, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24898525